Thrombophilia Global Market Report 2025

Thrombophilia Global Market Report 2025 – By Type (Factor V Leiden, Prothrombin 20210, Antiphospholipid Syndrome, Other Type), By Drugs (Heparin, Warfarin, Other Drugs), By Route Of Administration (Oral, Parenteral, Other Route Of Administration), By End-Users (Hospitals, Homecare, Specialty Centers, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

Name: Thrombophilia Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Thrombophilia Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

Thrombophilia Market Definition

Thrombophilia is a blood disorder that increases the risk of blood clotting in the veins and arteries. It can be caused by blood clotting in arteries and veins or by an inherited (genetic) or acquired disposition. It has the potential to cause a heart attack, stroke, kidney failure, and pulmonary embolism.

The main types of thrombophilia are factor V leiden, prothrombin 20210, antiphospholipid syndrome, and others. Factor V Leiden is a mutation in one of the blood-clotting factors. The drugs include Heparin, Warfarin, and others with a variety of administration routes, such as oral and parenteral. The end-users include hospitals, home health agencies, specialty centers, and others.

Thrombophilia Market Segmentation

The thrombophilia market covered in this report is segmented –

1) By Type: Factor V Leiden, Prothrombin 20210, Antiphospholipid Syndrome, Other Type

2) By Drugs: Heparin, Warfarin, Other Drugs

3) By Route Of Administration: Oral, Parenteral, Other Route Of Administration

4) By End-Users: Hospitals, Homecare, Specialty Centers, Other End Users

Subsegments:

1) By Factor V Leiden: Genetic Testing, Anticoagulant Therapy

2) By Prothrombin 20210: Genetic Testing, Anticoagulant Therapy

3) By Antiphospholipid Syndrome: Antiphospholipid Antibody Testing, Anticoagulant Therapy

4) By Other Types: Protein C Deficiency, Protein S Deficiency, Antithrombin III Deficiency, Other Genetic Conditions

Thrombophilia Global Market Report 2025 Market Size and growth rate 2025 to 2029: Graph

Thrombophilia Market Size 2025 And Growth Rate

The thrombophilia market size has grown strongly in recent years. It will grow from $17.03 billion in 2024 to $18.35 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to increasing awareness, research and development in anticoagulant therapies, aging population, genetic research, increased incidence of thrombotic disorders.

Thrombophilia Market Growth Forecast

The thrombophilia market size is expected to see strong growth in the next few years. It will grow to $25.12 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to personalized medicine, emergence of novel therapies, integration of artificial intelligence, healthcare policy and regulation, increased patient education and empowerment. Major trends in the forecast period include technological advancements, expanded role of telemedicine, rising incidence rates, biopharmaceutical developments, collaborative research initiatives.

Book your 30 minutes free consultation with our research experts

Thrombophilia Market Driver: Surge In Elderly Population Propels Growth In The Thrombophilia Market

An increase in the elderly population is expected to propel the growth of the thrombophilia market going forward. The elderly population refers to those aged 65 and up, with the proportion of the dependent population determined as the total elderly and youth population expressed as a ratio of the total population. Thrombophilic risk factors are common in elderly adults and allow for the identification of a population at risk for poor clinical outcomes, hence, the rise in the elderly population will boost the market as it creates demand for thrombophilia drugs. For instance, according to the data released by America’s Health Rankings, a US-based organization that evaluates health outcomes, in 2022, more than 56 million adults aged 65 and older account for around 16.9% of the total US population. More than 73.1 million older people are expected by 2030. Therefore, the increase in the elderly population is driving the growth of the thrombophilia market.

Thrombophilia Market Driver: Surge In Thrombophilic Conditions Fuels Growth In The Thrombophilia Market

The increasing prevalence of thrombophilic conditions is expected to propel the growth of the thrombophilia market in the coming years. Thrombophilic diseases, often known as thrombophilia, are a category of illnesses marked by an increased proclivity to develop blood clots (thrombosis). Thrombophilic conditions play an important role in the thrombophilia market, impacting diagnosis, treatment techniques, and current research. For instance, in August 2023, according to the Nuffield Trust, a UK-based nonprofit foundation whose purpose is to improve health care in the United Kingdom via evidence and analysis, when compared to the eight other nations that supplied data, the UK had the greatest number of cases of (Deep vein thrombosis) DVT were 352 in 2021. It increased to 377 for every 100,000 hospital discharges in 2022. Therefore, the increasing prevalence of thrombophilic conditions is driving the thrombophilia market.

Global Thrombophilia Market Major Players

Major companies operating in the thrombophilia market include Pfizer Inc., F. Hoffmann-La Roche Limited, Changzhaou Qianhong Bio-pharma Co. Limited, Fresenius Kabi AG, Hebei Changshan Biochemical Pharmaceutical Co. Limited, Hikma Pharmaceuticals PLC., Novartis AG, Shanghai Fosun Pharmaceutical (Group) Co. Ltd., Shenzhen Hepalink Pharmaceutical Group Co. Limited, Teva Pharmaceutical Industries Limited, Yino Pharma Limited, Sanofi SA, Eisai Co. Limited, Boehringer Ingelheim GmbH, Instrumentation Laboratory SpA, Johnson & Johnson, Laurus Lab, Bristol-Myers Squibb, Roche, Abbott, C. H. Boehringer Sohn, Portola Pharmaceuticals, Daiichi Sankyo, Bayer Group, GlaxoSmithKline plc, CSL Behring

Global Thrombophilia Market Trend: Groundbreaking Technological Advances And Long-Acting Drugs On The Horizon

Technological advancements are the key trend gaining popularity in the thrombophilia market. Major companies operating in the market are developing innovative technologies to sustain their position in the market. For instance, in May 2023, researchers at the University of California, San Diego, developed a groundbreaking technology known as Eloctate that holds the potential to transform the treatment of hemophilia. This innovative approach utilizes a novel fusion protein that significantly enhances the stability and half-life of coagulation factors in the bloodstream. By combining this technology with existing therapies, the researchers aim to create long-acting drugs that require less frequent administration, thereby improving patient compliance and quality of life.

Global Thrombophilia Market Trend: Strategic Partnerships Pioneer Biosynthetic Heparin Production For Enhanced Effectiveness

Major companies operating in the thrombophilia market are adopting a strategic partnership approach, aiming to create biosynthetic heparin. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in January 2022, Optimvia, LLC, a US-based biotechnology company, announced a partnership with Ginkgo Bioworks to increase the effectiveness of biosynthetic heparin synthesis. Optimvia intends to use Ginkgo's cell and enzyme engineering systems, as well as its fermentation manufacturing capabilities, to rapidly increase the performance of its biosynthetic heparin production method. Optimvia believes that combining its unique technique with Ginkgo's skills would result in commercially viable, cost-effective, and safe biosynthetic heparin that may completely reduce the world's reliance on livestock-sourced heparin. Ginkgo Bioworks is a US-based company that offers a platform for cell programming.

Thrombophilia Market Merger And Acquisition: Pfizer Expands Portfolio With Acquisition Of Arena Pharmaceuticals, Focusing On Innovations In Immuno-Inflammatory Disorders

In March 2022, Pfizer Inc., a US-based pharmaceutical company, acquired Arena Pharmaceuticals for $6.7 billion. With this acquisition, Arena Pharmaceuticals becomes a subsidiary of Pfizer and helps generate innovations to improve the lives of people suffering from immuno-inflammatory disorders. Arena Pharmaceuticals, Inc. is a US-based company aimed at treating thromboembolic disorders of the arterial blood vessels.

Regional Analysis For The Global Thrombophilia Market

North America was the largest region in the thrombophilia market in 2024. The regions covered in the thrombophilia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the thrombophilia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Thrombophilia Market?

The thrombophilia market consists of sales of rivaroxaban, apixaban, and thrombolytics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Thrombophilia Industry?

The thrombophilia market research report is one of a series of new reports from. The Business Research Company that provides thrombophilia market statistics, including thrombophilia industry global market size, regional shares, competitors with a thrombophilia market share, detailed thrombophilia market segments, market trends and opportunities, and any further data you may need to thrive in the thrombophilia industry. This thrombophilia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Thrombophilia Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$18.35 billion
Revenue Forecast In 2034	$25.12 billion
Growth Rate	CAGR of 8.2% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Type: Factor V Leiden, Prothrombin 20210, Antiphospholipid Syndrome, Other Type 2) By Drugs: Heparin, Warfarin, Other Drugs 3) By Route Of Administration: Oral, Parenteral, Other Route Of Administration 4) By End-Users: Hospitals, Homecare, Specialty Centers, Other End Users Subsegments: 1) By Factor V Leiden: Genetic Testing, Anticoagulant Therapy 2) By Prothrombin 20210: Genetic Testing, Anticoagulant Therapy 3) By Antiphospholipid Syndrome: Antiphospholipid Antibody Testing, Anticoagulant Therapy 4) By Other Types: Protein C Deficiency, Protein S Deficiency, Antithrombin III Deficiency, Other Genetic Conditions
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., F. Hoffmann-La Roche Limited, Changzhaou Qianhong Bio-pharma Co. Limited, Fresenius Kabi AG, Hebei Changshan Biochemical Pharmaceutical Co. Limited, Hikma Pharmaceuticals PLC., Novartis AG, Shanghai Fosun Pharmaceutical (Group) Co. Ltd., Shenzhen Hepalink Pharmaceutical Group Co. Limited, Teva Pharmaceutical Industries Limited, Yino Pharma Limited, Sanofi SA, Eisai Co. Limited, Boehringer Ingelheim GmbH, Instrumentation Laboratory SpA, Johnson & Johnson, Laurus Lab, Bristol-Myers Squibb, Roche, Abbott, C. H. Boehringer Sohn, Portola Pharmaceuticals, Daiichi Sankyo, Bayer Group, GlaxoSmithKline plc, CSL Behring
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Thrombophilia Market Characteristics

3. Thrombophilia Market Trends And Strategies

4. Thrombophilia Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Thrombophilia Growth Analysis And Strategic Analysis Framework

5.1. Global Thrombophilia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Thrombophilia Market Growth Rate Analysis

5.4. Global Thrombophilia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Thrombophilia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Thrombophilia Total Addressable Market (TAM)

6. Thrombophilia Market Segmentation

6.1. Global Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Factor V Leiden

Prothrombin 20210

Antiphospholipid Syndrome

Other Type

6.2. Global Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Heparin

Warfarin

Other Drugs

6.3. Global Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Parenteral

Other Route Of Administration

6.4. Global Thrombophilia Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Homecare

Speciality Centres

Other End Users

6.5. Global Thrombophilia Market, Sub-Segmentation Of Factor V Leiden, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Genetic Testing

Anticoagulant Therapy

6.6. Global Thrombophilia Market, Sub-Segmentation Of Prothrombin 20210, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Genetic Testing

Anticoagulant Therapy

6.7. Global Thrombophilia Market, Sub-Segmentation Of Antiphospholipid Syndrome, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Antiphospholipid Antibody Testing

Anticoagulant Therapy

6.8. Global Thrombophilia Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Protein C Deficiency

Protein S Deficiency

Antithrombin III Deficiency

Other Genetic Conditions

7. Thrombophilia Market Regional And Country Analysis

7.1. Global Thrombophilia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Thrombophilia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Thrombophilia Market

8.1. Asia-Pacific Thrombophilia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Thrombophilia Market

9.1. China Thrombophilia Market Overview

9.2. China Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Thrombophilia Market

10.1. India Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Thrombophilia Market

11.1. Japan Thrombophilia Market Overview

11.2. Japan Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Thrombophilia Market

12.1. Australia Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Thrombophilia Market

13.1. Indonesia Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Thrombophilia Market

14.1. South Korea Thrombophilia Market Overview

14.2. South Korea Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Thrombophilia Market

15.1. Western Europe Thrombophilia Market Overview

15.2. Western Europe Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Thrombophilia Market

16.1. UK Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Thrombophilia Market

17.1. Germany Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Thrombophilia Market

18.1. France Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Thrombophilia Market

19.1. Italy Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Thrombophilia Market

20.1. Spain Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Thrombophilia Market

21.1. Eastern Europe Thrombophilia Market Overview

21.2. Eastern Europe Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Thrombophilia Market

22.1. Russia Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Thrombophilia Market

23.1. North America Thrombophilia Market Overview

23.2. North America Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Thrombophilia Market

24.1. USA Thrombophilia Market Overview

24.2. USA Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Thrombophilia Market

25.1. Canada Thrombophilia Market Overview

25.2. Canada Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Thrombophilia Market

26.1. South America Thrombophilia Market Overview

26.2. South America Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Thrombophilia Market

27.1. Brazil Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Thrombophilia Market

28.1. Middle East Thrombophilia Market Overview

28.2. Middle East Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Thrombophilia Market

29.1. Africa Thrombophilia Market Overview

29.2. Africa Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Thrombophilia Market Competitive Landscape And Company Profiles

30.1. Thrombophilia Market Competitive Landscape

30.2. Thrombophilia Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. F. Hoffmann-La Roche Limited Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Changzhaou Qianhong Bio-pharma Co. Limited Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Hebei Changshan Biochemical Pharmaceutical Co. Limited Overview, Products and Services, Strategy and Financial Analysis

31. Thrombophilia Market Other Major And Innovative Companies

31.1. Hikma Pharmaceuticals PLC.

31.2. Novartis AG

31.3. Shanghai Fosun Pharmaceutical (Group) Co. Ltd.

31.4. Shenzhen Hepalink Pharmaceutical Group Co. Limited

31.5. Teva Pharmaceutical Industries Limited

31.6. Yino Pharma Limited

31.7. Sanofi SA

31.8. Eisai Co. Limited

31.9. Boehringer Ingelheim GmbH

31.10. Instrumentation Laboratory SpA

31.11. Johnson & Johnson

31.12. Laurus Lab

31.13. Bristol-Myers Squibb

31.14. Roche

31.15. Abbott

32. Global Thrombophilia Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Thrombophilia Market

34. Recent Developments In The Thrombophilia Market

35. Thrombophilia Market High Potential Countries, Segments and Strategies

35.1 Thrombophilia Market In 2029 - Countries Offering Most New Opportunities

35.2 Thrombophilia Market In 2029 - Segments Offering Most New Opportunities

35.3 Thrombophilia Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Thrombophilia Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Thrombophilia Market, Sub-Segmentation Of Factor V Leiden, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Thrombophilia Market, Sub-Segmentation Of Prothrombin 20210, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Thrombophilia Market, Sub-Segmentation Of Antiphospholipid Syndrome, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Thrombophilia Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Thrombophilia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Thrombophilia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Pfizer Inc. Financial Performance

Table 80: F. Hoffmann-La Roche Limited Financial Performance

Table 81: Changzhaou Qianhong Bio-pharma Co. Limited Financial Performance

Table 82: Fresenius Kabi AG Financial Performance

Table 83: Hebei Changshan Biochemical Pharmaceutical Co. Limited Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Thrombophilia Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Thrombophilia Market, Sub-Segmentation Of Factor V Leiden, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Thrombophilia Market, Sub-Segmentation Of Prothrombin 20210, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Thrombophilia Market, Sub-Segmentation Of Antiphospholipid Syndrome, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Thrombophilia Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Thrombophilia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Thrombophilia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Pfizer Inc. Financial Performance

Figure 80: F. Hoffmann-La Roche Limited Financial Performance

Figure 81: Changzhaou Qianhong Bio-pharma Co. Limited Financial Performance

Figure 82: Fresenius Kabi AG Financial Performance

Figure 83: Hebei Changshan Biochemical Pharmaceutical Co. Limited Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

The Microbiome Market Share, Market Size, And Growth Rate 2022

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the biosimilars market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the high potency apis market research report 2022 with industry size, share, segments and market growth

Anemia And Other Blood Disorder Drugs Global Market Report 2025 – By Type (Iron Deficiency Anemia, Chronic Kidney Disease Anemia, Sickle Cell Anemia, Aplastic Anemia), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospitals Pharmacy, Online Pharmacy, Pharmacy) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Drugs For Hormonal Replacement Therapy Global Market Report 2025 – By Therapy Type (Estrogen Replacement Therapy, Human Growth Hormone (HGH) Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application (Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, Menopause, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Biosimilars Global Market Report 2025 – By Type (Monoclonal Antibodies, Insulin, Erythropoietin, Granulocyte-Colony Stimulating Factor, Other Hormones, Others), By Product (Recombinant Non-glycosylated Proteins, Recombinant Glycosylated Proteins), By Application (Oncology, Chronic And Autoimmune Diseases, Growth Hormone Deficiency, Infectious Diseases, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Biosimilar Growth Hormones Global Market Report 2025 – By Route Of Administration (Intravenous, Subcutaneous, Intramuscular, Oral), By Application (Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader Willi Syndrome, Other Applications), By Distribution Channel (Hospital And Retail Pharmacy, Online Pharmacy/ePharmacy, Specialty Clinics) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Immunoglobulins Global Market Report 2025 – By Product (IGG, IGA, IGM, IGE, IGD. ), By Mode Of Delivery (Intravenous Mode of Delivery, Subcutaneous Mode of Delivery), By Application (Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, Idiopathic thrombocytopenic purpura (ITP), Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

STD Diagnostics Global Market Report 2025 – By Type( Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing, Other Types), By Location Of Testing( Laboratory Testing, Point Of Care (PoC) Testing), By End-User( Hospitals And Clinics, Diagnostic Centers, Homecare) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Intravenous Immunoglobulin Global Market Report 2025 – By Type( IgG (Immunoglobulin G), IgM (Immunoglobulin M), IgA (Immunoglobulin A), IgE (Immunoglobulin E), IgD (Immunoglobulin D)), By Distribution Channel( Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels ), By Application( Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Primary Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Other Applications ), By End-User( Hospitals, Clinics, Home Care) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Plasma Protein Therapeutics Global Market Report 2025 – By Product (Immunoglobulin, Albumin, Coagulation Factor, C1-esterase Inhibitors, Other Products), By Route Of Administration (Intravenous, Subcutaneous), By Applications (Primary Immunodeficiency Disorder (PID), Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency, Hereditary Angioedema, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the thrombophilia market?

How will the thrombophilia market drivers and restraints affect the thrombophilia market dynamics? What forces will shape the thrombophilia industry going forward?

The thrombophilia market major growth driver - Thrombophilia is a blood disorder that increases the risk of blood clotting in the veins and arteries. It can be caused by blood clotting in arteries and veins or by an inherited (genetic) or acquired disposition. It has the potential to cause a heart attack, stroke, kidney failure, and pulmonary embolism.. For further insights on the thrombophilia market, request a sample here

What is the forecast market size or the forecast market value of the thrombophilia market?

The thrombophilia market size has grown strongly in recent years. It will grow from $17.03 billion in 2024 to $18.35 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to increasing awareness, research and development in anticoagulant therapies, aging population, genetic research, increased incidence of thrombotic disorders. The thrombophilia market size is expected to see strong growth in the next few years. It will grow to $25.12 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to personalized medicine, emergence of novel therapies, integration of artificial intelligence, healthcare policy and regulation, increased patient education and empowerment. Major trends in the forecast period include technological advancements, expanded role of telemedicine, rising incidence rates, biopharmaceutical developments, collaborative research initiatives. For further insights on the thrombophilia market, request a sample here

How is the thrombophilia market segmented?

The thrombophilia market is segmented
1) By Type: Factor V Leiden, Prothrombin 20210, Antiphospholipid Syndrome, Other Type
2) By Drugs: Heparin, Warfarin, Other Drugs
3) By Route Of Administration: Oral, Parenteral, Other Route Of Administration
4) By End-Users: Hospitals, Homecare, Specialty Centers, Other End Users Subsegments:
1) By Factor V Leiden: Genetic Testing, Anticoagulant Therapy
2) By Prothrombin 20210: Genetic Testing, Anticoagulant Therapy
3) By Antiphospholipid Syndrome: Antiphospholipid Antibody Testing, Anticoagulant Therapy
4) By Other Types: Protein C Deficiency, Protein S Deficiency, Antithrombin III Deficiency, Other Genetic Conditions For further insights on the thrombophilia market, request a sample here

Which region has the largest share of the thrombophilia market? What are the other regions covered in the report?

North America was the largest region in the thrombophilia market in 2024. The regions covered in the thrombophilia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the thrombophilia market, request a sample here.

Who are the major players in the thrombophilia market?

What are the key trends in the thrombophilia market?

Major trend in the thrombophilia market - Groundbreaking Technological Advances And Long-Acting Drugs On The Horizon. For further insights on the thrombophilia market, request a sample here.

What are the major opportunities in the thrombophilia market? What are the strategies for the thrombophilia market?

For detailed insights on the major opportunities and strategies in the thrombophilia market, request a sample here.

How does the thrombophilia market relate to the overall economy and other similar markets?

For detailed insights on thrombophilia market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the thrombophilia industry?

For detailed insights on the mergers and acquisitions in the thrombophilia industry, request a sample here.

What are the key dynamics influencing the thrombophilia market growth? SWOT analysis of the thrombophilia market.

For detailed insights on the key dynamics influencing the thrombophilia market growth and SWOT analysis of the thrombophilia industry, request a sample here.